Longwood Medical Area in Boston is one of the densest medical communities in the country. The 213-acre neighborhood houses four teaching hospitals, a medical school, and a diabetes research center and clinic. Five of those institutions — Boston Children’s Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, and Joslin Diabetes Center are affiliated with Harvard Medical School, which relies on them to train its students. In September 2017, Boston Children’s Hospital began construction of a $1 billion state-of-the-art clinical building.Read More
Science Market Update
Tags: Longwood Medical, Harvard University, cancer research, Massachusetts, Longwood Medical Center, Boston, MA, new medical buildings, laboratory suppliers, BioResearch Product Faire, laboratory products
Harvard Medical School, with facilities in the Longwood are aof Boston, is the third oldest medical school in the United States, founded in 1782, and is home to more than 700 students in the M.D. program, more than 140 in the D.M.D program, 556 in the Ph.D. program, and 155 in the M.D.‑Ph.D. program. Harvard Medical School is also affiliated with several teaching hospitals: the Beth Israel Deaconess Medical Center, the Brigham and Women’s Hospital and the Massachusetts General Hospital.
The Longwood Medical Area is known as one of the most prestigious educational, medical and research areas in the United States. Located along Longwood Avenue in Boston, Massachusetts, Longwood Medical Area (LMA) is made up of teaching hospitals, medical facilities, and non-medical facilities; as well as some top educational institutes, such as Harvard Medical School.
Cancer Research UK released a staggering statistic in 2014: 46% of people who have cancer are diagnosed during stages 3 or 4; these late stage diagnoses greatly reduce the chances of survival, as treatment success drops once cancer has progressed to such an advanced stage.Read More
Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.Read More
Six teams of researchers from leading univerisites are going to receive a set of three-year grants, totaling over $7.5 million, to create lab-grown brain cells in a process called neuronal maturation.
The funding to the various universities was made possible by The Paul G. Allen Family Foundation as part of its Allen Distinguished Investigator grants, and will ensure the continued development of important neuroscience research.Read More
Tags: CA, Harvard University, Washington, Parkinson's Disease Research, California, brain research, 2015, Alzheimer' Research, LAVS, Neuroscience, BioResearch Product Faire Event, Research Funding, Harvard, UCSF, longwood, Biotechnology Vendor Showcase Event, best lab supply tradeshows, best science tradeshows
Scientists at Harvard Medical have made a recent breakthrough in cancer therapy research with the help of three separate grants from the National Institutes of Health, totaling over $1,153,000.Read More
Tags: Harvard University, breast cancer research, cancer research, Massachusetts, Longwood Medical Center, 2015, Boston, BioResearch Product Faire Event, Harvard Medical, MA, Harvard, NIH funding, research grants, breast cancer funding, NIH grants, cancer research funding, best lab supply tradeshows, best science tradeshows
The Joslin Translational Center for the Cure of Diabetes opens at the Longwood Medical Center with a ribbon cutting ceremony this week.
Harvard is still one of the most richly funded research universities in the world. Although much of its available monies come from private foundations and donations, Harvard also draws millions of dollars annually in government sponsored research. The 2014 most recent stats are listed below:
Researchers at Harvard University have recently published the results of a human clinical trial of a therapeutic that could increase the chances of success for blood stem cell transplantation. This will be the first time that the Harvard Stem Cell Institute has brought a discovery from the lab through clinical trials, marking the success of Harvard’s nine year-old goal of conducting groundbreaking research through the institute.
Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering recently received $3.5 million in life science funding from the NIH. The grant is called a Transformative Research Award. The NIH’s aim in creating this grant is to fund high-risk, high-reward research. According to News Medical, the NIH funded only 10 of these projects in 2013, one of which is Harvard University’s DNA-based microscopy method of viewing cells.